Market Research Future published a research report on “Global Retinal Vein Occlusion Market” to track and analyses developments which are competitive in nature such as strategic alliances, mergers and acquisitions, new product developments along with research and developments currently taking place in the Global Retinal Vein Occlusion Market.
Request Premium Sample copy at https://www.marketresearchfuture.com/sample_request/5377
Retinal Vein Occlusion Market – Highlights:
Glaucoma is a condition where the eye pressure causes damage to the optic nerve. The increasing number of patients with glaucoma is leading the retinal vein occlusion market offering a huge growth opportunity to the market players. Moreover, the growing number of patients affected with lymphoma and multiple myeloma is also fueling the growth of the global retinal vein occlusion market.
According to the Centers for Disease Control and Prevention, in 2014, around 47,135 people were diagnosed with leukemia and out of which 23,564 people died from the disease. According to the American Cancer Society, around 4% of all cancers in the United States is lymphoma, additionally, it is estimated that in 2018, about 74,680 people including both adults and children will be diagnosed with lymphoma and around 19,910 people will die from this. According to the American Cancer Society, the risk of acquiring multiple myeloma in the United States is 1 in 143 that is 0.7%, additionally, it is estimated that in 2018, around 30,770 new cases are likely to be diagnosed and the estimated death toll would be around 12,770.
The Global Retinal Vein Occlusion Market Is Expected To Grow At A CAGR Of 11.2% During The Forecast Period 2018-2023.
Renowned Players:
Allergan, Bayer
Bristol-Myers Squibb
Regeneron Pharmaceuticals
Ellex Medical Lasers
And more.
Global Retinal Vein Occlusion Market – Segments
The global retinal vein occlusion market is segmented on the basis of type, condition, diagnosis, treatment, and end user. On the basis of the type, it is segmented into branch retinal artery occlusion and central retinal vein occlusion. On the basis of the condition, it is segmented into non-ischemic and ischemic. Based on the diagnosis, it is segmented into optical coherence tomography (OCT), fundoscopic examination, fluorescein angiography, and others. On the basis of treatment, it is segmented into antivascular endothelial growth factor, corticosteroid drugs, laser retinal photocoagulation, and others. On the basis of the end users, it is segmented into hospitals and clinics, research & academics centers, and others.
Retinal Vein Occlusion Market – Regional Analysis
The Americas dominate the Global Retinal Vein Occlusion Market owing to the increasing prevalence of patients, the presence of major market players, improvement in surgical outcomes, the presence of a strong economic condition, and focus of research institutions on updating technology for new and advanced treatment methods for retinal vein occlusion.
Europe holds the second position in the market owing to increasing support from the government, the presence of huge geriatric population, and high healthcare spending. According to the Organization for Economic Co-operation and Development (OECD), the healthcare expenditure in Germany was EUR 321 billion in 2014, France recorded the second highest level of current health care expenditure of EUR 237 billion.
Asia Pacific is the fastest growing market owing to more number of developing nations present in this region, for instance, countries like India and China. These countries are encouraging the growth of the retinal vein occlusion market.
Major TOC of Retinal Vein Occlusion Market Research Report – Forecast to 2023
1 Report Prologue
2 Market Introduction
3 Research Methodology
4 Market Dynamics
5 Market Factor Analysis
6 Global Retinal Vein Occlusion Market, By Type
7 Global Retinal Vein Occlusion Market, By Condition
8 Global Retinal Vein Occlusion Market, By Diagnosis
9 Global Retinal Vein Occlusion Market, By Treatment
10 Global Retinal Vein Occlusion Market, By End User
11 Global Retinal Vein Occlusion Market, By Region
12 Competitive Landscape
13 Company Profiles
14 MRFR Conclusion
15 Appendix
Inquire more about this Report at https://www.marketresearchfuture.com/enquiry/5377
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
